In a world where accurate and rapid diagnostics are crucial for effective patient care, FlashDx’s Respiratory Panel 1.1 stands as a remarkable leap forward. The expanded range of pathogens, coupled with its seamless sample extraction process, ensures that healthcare providers can make informed decisions swiftly and confidently.
Contact us today to schedule a demonstration and learn more about how this breakthrough technology can transform your practice
Brochure
For any missing information or if you require additional details, please do not hesitate to contact us.
Respiratory Panel 1.1: Simultaneous Testing for an Expanded Range of Pathogens
In the field of point-of-care testing (POCT), FlashDx, a pioneer in rapid and accurate diagnostic solutions, is proud to announce an enhancement to their existing Respiratory Panel 1.0. The newly introduced Respiratory Panel 1.1 takes the capabilities of POCT to new heights by incorporating an extended array of pathogens. This expansion enables healthcare professionals to swiftly and precisely perform a battery of tests, thereby enhancing the efficiency and comprehensiveness of diagnostic processes.
The enhanced panel empowers medical practitioners to simultaneously test for an array of infectious agents, including:
– Sars-CoV-2
– Influenza A and B
– Adenovirus
– Respiratory Syncytial Virus
– Human Rhinovirus/Enterovirus
– Bordetella pertussis
– Human Metapneumovirus
– Parainfluenza virus 1, 2, and 3
– Mycoplasma pneumoniae
The Respiratory Panel 1.1 includes a streamlined, user-friendly extraction process that completes in under a minute, allowing healthcare providers to focus on patient care.
Demo units of the FlashDx Respiratory Panel 1.1 are available for healthcare institutions interested in exploring its capabilities. Our team can provide explanations and demonstrations of the panel’s features at your convenience. Please contact us to arrange a visit.
The kit includes tests for Sars-CoV-2, Influenza A/B, Adenovirus, RSV, Rhinovirus, Bordetella, Metapneumovirus, Parainfluenza, and Mycoplasma.
Subscribe to our newsletter.